Business Context and Reporting Period
This Form 8-K filing by Prestige Brands Holdings, Inc. (now Prestige Consumer Healthcare Inc.) covers events occurring on January 31, 2006. The report details corporate governance changes, specifically the expansion of the Board of Directors and the reorganization of key board committees to comply with New York Stock Exchange (NYSE) independence requirements.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. Item 9.01 explicitly states that no financial statements or pro forma financial information are included in this report.
Material Changes
- Board Expansion: The Board of Directors increased its size from seven to ten members, creating three new vacancies.
- New Appointments: John E. Byom, Raymond P. Silcock, and Frank Palantoni were elected to fill the vacancies.
- Independence Designations: Mr. Byom and Mr. Silcock were designated as "independent" directors per SEC and NYSE standards.
- Committee Restructuring: The Audit, Compensation, and Nominating and Governance Committees were reconstituted to consist entirely of independent directors.
- Financial Expertise: The Board determined that all Audit Committee members meet financial literacy requirements, and Mr. Byom was designated as an "audit committee financial expert."
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, risks, contingencies, or unusual items. The document is strictly a disclosure of corporate governance actions.
Key Facts for Investor Verification
- Verify the professional backgrounds and potential conflicts of interest for the three newly appointed directors: John E. Byom, Raymond P. Silcock, and Frank Palantoni.
- Confirm that the restructured committee compositions align with the specific independence rules of the NYSE effective as of the filing date.
- Note that this filing does not contain financial performance data; investors should refer to the most recent 10-K or 10-Q for financial metrics.